Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 6/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | VHL | P40337 | 1/20 | 0.42 |
| ▸ | ELOC | Q15369 | 1/20 | 0.42 |
| ▸ | ELOB | Q15370 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL127369 | 0.83 | IDO1 (0.69) | IDO1TSHRFOLH1 | |
| SCHEMBL41775 | 0.83 | TSHR (0.67) | TSHRPRSS1PRSS2PRSS3VHL | |
| SCHEMBL22408786 | 0.77 | CA2 (0.59) | IDO1TSHRCA12CA1CA2 | |
| SCHEMBL31672218 | 0.76 | TSHR (0.59) | TSHRPRSS1PRSS2PRSS3VHL | |
| SCHEMBL12482033 | 0.75 | ACHE (0.48) | IDO1TSHRFOLH1ACHE | |
| SCHEMBL2642543 | 0.75 | — | — | |
| SCHEMBL494668 | 0.75 | — | — | |
| SCHEMBL544552 | 0.75 | — | — | |
| SCHEMBL11310791 | 0.73 | MKNK1 (0.56) | TSHRPRSS1PRSS2PRSS3VHL | |
| SCHEMBL679970 | 0.73 | MKNK1 (0.56) | TSHRPRSS1PRSS2PRSS3VHL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025053791-A1 | ONE-POT GRAFTING OF POLYMERS FROM ALCOHOLS AND BIOMASSES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-03-13 | — | — | WO | claimed |
| EP-1752463-B1 | NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX | SAN APRO LTD (JP) | 2013-07-17 | — | — | EP | claimed |
| CN-122070173-A | Microfluidic system, reaction method using microfluidic system, and method for producing polymer | 株式会社大赛璐 | 2026-05-19 | — | — | CN | disclosed |
| WO-2025079623-A1 | METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079618-A1 | MICROFLUIDIC SYSTEM, REACTION METHOD FOR EMPLOYING MICROFLUIDIC SYSTEM, AND METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079622-A1 | MICROFLUIDIC SYSTEM, REACTION METHOD USING MICROFLUIDIC SYSTEM, AND METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079620-A1 | MICROFLUIDIC SYSTEM, PROCESSING METHOD USING MICROFLUIDIC SYSTEM, AND METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079624-A1 | METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025053791-A1 | ONE-POT GRAFTING OF POLYMERS FROM ALCOHOLS AND BIOMASSES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-03-13 | — | — | WO | disclosed |
| US-20200292939-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE DRY FILM, METHOD OF MANUFACTURING PHOTOSENSITIVE DRY FILM, METHOD OF MANUFACTURING PATTERNED RESIST FILM, METHOD OF MANUFACTURING SUBSTRATE WITH TEMPLATE AND METHOD OF MANUFACTURING PLATED ARTICLE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-09-17 | — | — | US | disclosed |
| CN-107531906-B | Novel optical material composition containing mercaptan compound | 三菱瓦斯化学株式会社 | 2018-12-04 | — | — | CN | disclosed |
| US-20100069381-A1 | GSK-3BETAINHIBITOR | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-03-18 | — | — | US | disclosed |
| EP-1651596-B1 | NOVEL DERIVATIVES OF 4,4'-DITHIOBIS-(3-AMINOBUTANE-1-SULFONATES) AND COMPOSITIONS COMPRISING THE SAME | INST NAT SANTE RECH MED (FR) | 2010-01-13 | — | — | EP | disclosed |
| US-7582797-B2 | Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same | INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-09-01 | — | — | US | disclosed |
| US-20080176816-A1 | Method of making and using an adenosine analogue | ACADEMIA SINICA | 2008-07-24 | — | — | US | disclosed |
| US-7351434-B2 | Therapeutic Gastrodia extracts | ACADEMIA SINICA (TW) | 2008-04-01 | — | — | US | disclosed |
| US-20070237840-A1 | Administering bis(4-hydroxybenzyl)sulfide for therapy of Huntington's disease | ACADEMIA SINICA (TW) | 2007-10-11 | — | — | US | disclosed |
| US-7144954-B2 | Highly transparent plastic for optical materials | Röhm GmbH & Co. KG (DE) | 2006-12-05 | — | — | US | disclosed |
| US-20050261421-A1 | Highly transparent plastic for optical materials | ROEHM GMBH & CO. KG (DE) | 2005-11-24 | — | — | US | disclosed |
| WO-2005014535-A1 | NOVEL DERIVATIVES OF 4,4'-DITHIOBIS-(3-AMINOBUTANE-1-SULFONATES) AND COMPOSITIONS COMPRISING THE SAME | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2005-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176816-A1 | Method of making and using an adenosine analogue | HTT, ADA, GDA | IDO1 3619/4885TSHR 1679/4885PRSS1 4125/4885 |
| US-20100069381-A1 | GSK-3BETAINHIBITOR | GSK3B, GSK3A, GSKIP | IDO1 1290/4885TSHR 4379/4885PRSS1 1723/4885 |
| US-20070237840-A1 | Administering bis(4-hydroxybenzyl)sulfide for therapy of Huntington's disease | HTT, SNCA, SLC2A4 | IDO1 4487/4885TSHR 2518/4885PRSS1 1719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.